Elicitation of protective immune responses using a bivalent H5N1 VLP vaccine.

Virol J · 2008 · PMC2583969 · PMID 18957098

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

These results are highly significant and demonstrate that a multivalent vaccine against H5N1 appears to be a plausible strategy to combat the diversity of clades and subclades of H5N1 influenza.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.